Results 181 to 190 of about 31,245 (262)

Integrating Equity in Topic Selection for Orphan Medicinal Products: Policy Implications for Health Technology Assessment in Rare Diseases. [PDF]

Appl Health Econ Health Policy
Hosseini F, Mobinizadeh M, Padula WV.
europepmc   +1 more source

Information Design for Early‐Stage Dose‐Finding Trials

Naval Research Logistics (NRL), EarlyView.
ABSTRACT To enhance enrollment rates in early‐stage dose‐finding clinical trials, we propose an information design approach, where the clinical investigator (CI) commits to an information releasing mechanism (IRM) based on the treatment's uncertain efficacy and toxicity to encourage patients to participate in the trial.
Amin Khademi, Ningyuan Chen
wiley   +1 more source

Transferable Exclusivity Extension Vouchers for Antimicrobials: Incentive Design, Implementation Challenges, and Policy Trade-Offs. [PDF]

Pharmacoecon Open
García-Díaz M, Mestre-Ferrándiz J, Espín J.   +2 more
europepmc   +1 more source

Unlocking potential: Development finance reforms needed to support localized health product manufacturing. [PDF]

PLOS Glob Public Health
Lynch S, Adetifa I, Dong J, Matiru R, Parshall C.   +4 more
europepmc   +1 more source

The impact of patent activity on idiosyncratic volatility in U.S. pharmaceutical companies. [PDF]

PLoS One
Atilgan E, Türkmen Ceylan FB, Doruk ÖT, Ertuğrul HM, Barak AY.   +4 more
europepmc   +1 more source

Stabilising Routines in Complex Emergencies: How Basic Service Continuity Shapes Perceived Security

Public Administration and Development, EarlyView.
ABSTRACT This study examines how locally embedded actors describe the relationship between basic service continuity and perceived security in complex emergencies, with particular attention to the stabilisation of everyday routines. Using Proximity‐Predictability‐Attributability (PPA) as an analytic lens, we trace how interviewees relate access to water,
Abdullah Gökhan Yaşa, Orçun İmga
wiley   +1 more source

Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies. [PDF]

Front Pharmacol
Simoens S, Dodwell D, Hartevelt M, Lindgren P, Pistollato M, Pont LG, Pontes C, Roediger A, Sablek A, Van Ganse E, Wang Q, Wenger C, Wilsdon T, Xoxi E, Godman B.   +14 more
europepmc   +1 more source

The Economic Wisdom of Regulating Pharmaceutical "Freebies"

Duke Law Journal, 1991
openaire   +3 more sources

Bioconversion and characterization of watermelon rind waste‐based microcrystalline cellulose: A green alternative to synthetic reinforcements

Polymer International, EarlyView.
Microcrystalline cellulose (MCC) was extracted from watermelon rind using acid hydrolysis. MCC can be efficiently used as reinforcement in biofilms and biocomposites. Abstract The increasing accumulation of agricultural waste from watermelon (Citrullus lanatus) represents a substantial environmental concern, particularly in view of the extensive ...
Indran Suyambulingam, Sunesh Narayanaperumal, Divya Divakaran, Nadir Ayrilmis, P Senthamaraikannan, Siva Avudaiappan, Yamuna Munusamy, H Jeevan Rao   +7 more
wiley   +1 more source

Contribution of Medication Expenditures to Catastrophic Health Expenditures in Iran: An Inequality Analysis. [PDF]

J Prev Med Public Health
Mousav A, Daroudi R, Akbari Sari A, Gholami M, Mohammadpour S, Fazaeli AA.   +5 more
europepmc   +1 more source